SecBot SecBot

ECOR

electroCore, Inc.
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001560258 Healthcare & Medical Devices
$7.44 +0.39 (+5.53%)
Oct 26 4:00 PM ET · prev $7.05
Market cap
$66.8M
Micro cap
Median target
$19.85
+167% · range $12.00–26.00
Next earnings
Nov 3
in 8 days · EPS est. −$0.27
1 year
+51.8%
from $4.90 · Oct 27
30 days
−32.5%
from $11.03
52-week range
$4.42–12.29
−39% from high · low Dec 18
Avg volume 20D
78.1K
shares / day
Short interest
🔒 Subscribers only
Insider net
−$713.2K
2 buyers · 2 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
6
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 3, 2026
Strongest NEUTRAL electroCore appointed Joshua Lev and Michael Fox as co-CEOs and Class III directors, effective September 8…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders bought $207.2K at an average $8.29. 2 insiders sold $920.4K. Price is 10% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 4 added (0 new), 1 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.286 → −$0.272 over 90 days. 3 up, 1 down in 30 days.

  • TrendDOWNTREND

    23% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
NORTHERN TRUST CORPDOUBLED66,506$574.6K
RENAISSANCE TECHNOLOGIES LLCTRIM19,900$171.9K
WELLS FARGO & COMPANY/MNADD598$5.2K
MORGAN STANLEYADD467$4.0K
JPMORGAN CHASE & CODOUBLED74$601.00
MORGAN STANLEYNEAR_EXIT367$2.2K
RENAISSANCE TECHNOLOGIES LLCTRIM54,486$244.4K
MORGAN STANLEYDOUBLED4,202$18.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jan 2026
12-month targets · 5 analysts

Price is below the lowest target. Median implies +167%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Jan 26, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Mar 13, 2025Ladenburg Thalmann
MAINTAIN
MAINTAINBuy
Mar 13, 2025HC Wainwright & Co.
REITERATE
REITERATEBuy
Dec 18, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Mar 14, 2024HC Wainwright & Co.
REITERATE
REITERATEBuy
Jan 22, 2024HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$207.2K
bought · 2 insiders
$920.4K
sold · 2 insiders
−10.3%
vs their $8.29 cost
DateInsiderTypeValue
Sep 14, 2026
Errico Thomas J.
Director
BUY$49.1K
Sep 11, 2026
Fox Michael
See Remarks
AWARD$49.0K
Sep 11, 2026
Fox Michael
See Remarks
BUY$49.0K
Sep 9, 2026
Theofilos James Charles
Director
AWARD11,123 sh
Sep 9, 2026
GANDOLFO JOHN P
Director
AWARD11,123 sh
Sep 9, 2026
Wilber Patricia
Director
AWARD11,123 sh
Sep 9, 2026
Goldstein Julie Ann
Director
AWARD11,123 sh
Sep 9, 2026
Errico Thomas J.
Director
AWARD15,572 sh

Earnings setup

Estimates
Nov 3
reports in 8 days
−$0.27
EPS estimate, this quarter
+5%
estimate change, 90 days
3↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.27-$0.31–-$0.23-0.7%$10.9M
Next Q-$0.21-$0.26–-$0.13+2.8%$12.0M
Current FY-$1.38-$1.48–-$1.24+7.3%$41.9M
Next FY-$0.62-$0.85–-$0.29-43.1%$54.4M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 14, 2026 Insider
Errico Thomas J. bought 5,000 shares
Director @ $9.82 ($49.1K)
Sep 11, 2026 Insider
Fox Michael was granted 5,000 shares
See Remarks @ $9.80 ($49.0K)
Sep 11, 2026 Insider
Fox Michael bought 5,000 shares
See Remarks @ $9.80 ($49.0K)
Sep 9, 2026 SEC
electroCore appointed Joshua Lev and Michael Fox as co-CEOs and Class III directors, effective September 8, 2026, with…
8-K — Impact 3/10
Aug 25, 2026 Routine
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
Recognition highlights Truvaga’s combination of patented non-invasive vagus nerve stimulation techno
Jun 30, 2026 Inst.
NORTHERN TRUST CORP — DOUBLED
66,506 shares ($574.6K)
Jun 30, 2026 Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
19,900 shares ($171.9K)
May 27, 2026 SEC
Director Thomas M. Patton filed a Form 144 indicating intent to sell 85,000 shares of electroCore (ECOR) valued at…
144 — Impact 2/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 3, 2026
Earnings date
ECOR Q3 2026 Earnings Scheduled — 2026-11-03
Recent
Aug 25, 2026
Company news
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
Recognition highlights Truvaga’s combination of patented non-invasive vagus nerve stimulation technology, thoughtful design and personalized…
Aug 6, 2026
Earnings date
ECOR Q2 2026 Earnings Scheduled — 2026-08-06
Aug 4, 2026
Earnings date
ECOR Q2 2026 Earnings Scheduled — 2026-08-04
Aug 3, 2026
Press release
electroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., Aug. 03, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company…
Jul 16, 2026
Press release
New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
ROCKAWAY, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company…

SecBot reports

6 filings · 3 press releases · 0 bullish · 0 bearish · 6 neutral
All ECOR filing & press-release reports (9)